tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CorMedix completes acquisition of Melinta Therapeutics

CorMedix (CRMD) completed its previously announced acquisition of Melinta Therapeutics, a private commercial-stage company providing innovative therapies for acute and life-threatening illnesses. Acquisition is expected to be highly accretive in 2026.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1